Display options
Cite
Lang J, Chah QT, Lançon JP, et al. Potentiation by acetylcholine of the effects of a calcium channel activator, Bay k 8644, on dog atria in situ. Naunyn Schmiedebergs Arch Pharmacol. 1987;335(3):334-9doi: 10.1007/BF00172807.
Lang, J., Chah, Q. T., Lançon, J. P., Charve, P., Aupetit, J. F., Loufoua-Moundanga, J., & Faucon, G. (1987). Potentiation by acetylcholine of the effects of a calcium channel activator, Bay k 8644, on dog atria in situ. Naunyn-Schmiedeberg's archives of pharmacology, 335(3), 334-9. https://doi.org/10.1007/BF00172807
Lang, J, et al. "Potentiation by acetylcholine of the effects of a calcium channel activator, Bay k 8644, on dog atria in situ." Naunyn-Schmiedeberg's archives of pharmacology vol. 335,3 (1987): 334-9. doi: https://doi.org/10.1007/BF00172807
Lang J, Chah QT, Lançon JP, Charve P, Aupetit JF, Loufoua-Moundanga J, Faucon G. Potentiation by acetylcholine of the effects of a calcium channel activator, Bay k 8644, on dog atria in situ. Naunyn Schmiedebergs Arch Pharmacol. 1987 Mar;335(3):334-9. doi: 10.1007/BF00172807. PMID: 2438563.
Copy Download .nbib Format: NLM
Share it on

Naunyn Schmiedebergs Arch Pharmacol. 1987 Mar;335(3):334-9. doi: 10.1007/BF00172807.

Potentiation by acetylcholine of the effects of a calcium channel activator, Bay k 8644, on dog atria in situ.

Naunyn-Schmiedeberg's archives of pharmacology

J Lang, Q T Chah, J P Lançon, P Charve, J F Aupetit, J Loufoua-Moundanga, G Faucon

PMID: 2438563 DOI: 10.1007/BF00172807

Abstract

The effects of Bay k 8644 were studied in the canine in situ heart under vagal influence and out of this influence on sinus rate and sinus recovery time, conduction time and effective refractory period (ERP) in the atrioventricular (AV) node and ERP of the atrial muscle. Bay k 8644, intravenously infused at the 2 micrograms X kg-1 X min-1 rate for 30 min, enhanced the inhibition of the atrial specialized tissue as well as the shortening of the atrial muscle ERP during vagal activity, elicited by the injection of dextromoramide into the cisterna magna. It did not develop any atrial action in the absence of vagal activity, suppressed by atropine. The reflex increase of vagal tone, in response to a small increase in blood pressure produced by Bay k 8644, is not the only cause of the phenomena observed in the former case. The observations can be explained primarily in terms of an interaction between Bay k 8644 and acetylcholine (ACh):ACh intraaortically injected near the coronary ostia, in a dose just sufficient to slow down sinus rate before Bay k 8644, reduced the rate by 50% at the end of a 60 min infusion of Bay k 8644 and the ACh threshold dose necessary to elicit a short third degree AV block before Bay k 8644 was reduced by 50% at the end of a 30 min infusion of Bay k 8644. Therefore, ACh appeared to be capable of enhancing the effects of a calcium channel activator as well as the effects of hypercalcaemia, as earlier reported.

Similar articles

References

  1. Circ Res. 1974 Feb;34(2):184-92 - PubMed
  2. J Pharmacol. 1983 Jul-Sep;14(3):361-72 - PubMed
  3. Arch Int Pharmacodyn Ther. 1977 Jun;227(2):206-19 - PubMed
  4. Proc Natl Acad Sci U S A. 1984 Aug;81(15):4824-7 - PubMed
  5. Am J Physiol. 1979 Jan;236(1):C1-8 - PubMed
  6. Pharmacol Rev. 1985 Mar;37(1):1-24 - PubMed
  7. Am J Physiol. 1967 Feb;212(2):424-30 - PubMed
  8. Eur J Pharmacol. 1984 Jul 20;102(3-4):555-7 - PubMed
  9. J Gen Physiol. 1976 May;67(5):599-617 - PubMed
  10. Life Sci. 1985 Nov 18;37(20):1843-60 - PubMed
  11. Circ Res. 1955 Jul;3(4):390-6 - PubMed
  12. Am Heart J. 1973 Aug;86(2):203-10 - PubMed
  13. Naunyn Schmiedebergs Arch Pharmacol. 1985 Apr;329(2):182-7 - PubMed
  14. Nature. 1975 Jan 24;253(5489):273-4 - PubMed
  15. J Cardiovasc Pharmacol. 1986 Jan-Feb;8(1):6-13 - PubMed
  16. Int J Cardiol. 1984 Dec;6(6):743-6 - PubMed
  17. Circ Res. 1984 Oct;55(4):549-53 - PubMed
  18. Circ Res. 1959 Jan;7(1):19-23 - PubMed
  19. Circulation. 1974 Jan;49(1):32-41 - PubMed
  20. Circulation. 1981 May;63(5):1140-9 - PubMed
  21. Am J Cardiol. 1971 Mar;27(3):272-6 - PubMed
  22. Circ Res. 1972 Feb;30(2):210-6 - PubMed
  23. Fed Proc. 1981 Jun;40(8):2226-32 - PubMed
  24. Nature. 1983 Jun 9-15;303(5917):535-7 - PubMed
  25. Br J Pharmacol. 1985 Feb;84(2):577-84 - PubMed
  26. Biomed Biochim Acta. 1984;43(12):1385-97 - PubMed
  27. J Pharmacol. 1985 Apr-Jun;16(2):125-37 - PubMed
  28. Am J Cardiol. 1976 Jun;37(7):1079-85 - PubMed
  29. J Mol Cell Cardiol. 1984 Jul;16(7):667-70 - PubMed
  30. J Gen Physiol. 1969 Nov;54(5):607-35 - PubMed
  31. Arzneimittelforschung. 1983;33(9):1268-72 - PubMed
  32. J Physiol. 1979 Apr;289:347-73 - PubMed
  33. Circ Res. 1985 Jan;56(1):87-96 - PubMed
  34. J Mol Cell Cardiol. 1984 Jan;16(1):65-77 - PubMed
  35. Naunyn Schmiedebergs Arch Pharmacol. 1983 Feb;322(1):59-64 - PubMed
  36. J Physiol. 1982 Aug;329:589-614 - PubMed
  37. Cardiovasc Res. 1983 Dec;17(12):756-61 - PubMed
  38. Circulation. 1978 May;57(5):880-9 - PubMed
  39. Naunyn Schmiedebergs Arch Pharmacol. 1981 Apr;316(2):178-85 - PubMed
  40. Eur J Pharmacol. 1985 Jul 31;113(3):447-51 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources